1. Targeting ceramide metabolism in obesity
   Hanin Aburasayn et al, 2016, American Journal of Physiology-Endocrinology and Metabolism CrossRef
2. Sphingosine 1‐phosphate combining with S1PR4 promotes regulatory T cell differentiation related to FAO through Nrf2/PPARα
   Rui Feng et al, 2023, Scandinavian Journal of Immunology CrossRef
3. Sphingosine‐1‐phosphate in mitochondrial function and metabolic diseases
   Meng Duan et al, 2022, Obesity Reviews CrossRef
4. Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology
   Timothy Rohrbach et al, 2017, Critical Reviews in Biochemistry and Molecular Biology CrossRef
5. FTY720 Improves the Survival of Autologous Fat Grafting by Modulating Macrophages Toward M2 Polarization Via STAT3 Pathway
   Yi Yi et al, 2021, Cell Transplantation CrossRef
6. Sphingolipids in adipose tissue: What's tipping the scale?
   Johana M. Lambert et al, 2018, Advances in Biological Regulation CrossRef
7. S1P/S1PR3 signalling axis protects against obesity-induced metabolic dysfunction
   Sagarika Chakrabarty et al, 2022, Adipocyte CrossRef
8. Regulation of the metabolism of apolipoprotein M and sphingosine 1-phosphate by hepatic PPARγ activity
   Makoto Kurano et al, 2018, Biochemical Journal CrossRef
9. Sphingosine 1-Phosphate Regulates Obesity and Glucose Homeostasis
   Kazuo Kajita et al, 2024, International Journal of Molecular Sciences CrossRef
10. WITHDRAWN: Ceramide and Sphingosine 1-Phosphate in adipose dysfunction
    Zijian Fang et al, 2019, Progress in Lipid Research CrossRef
11. Ceramide and sphingosine 1-phosphate in adipose dysfunction
    Zijian Fang et al, 2019, Progress in Lipid Research CrossRef
12. S1P Signaling Pathways in Pathogenesis of Type 2 Diabetes
    Qiong He et al, 2021, Journal of Diabetes Research CrossRef